Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia

Modern Pathology

Volumn 23, Issue 9, 2010, Pages 1251-1260

  Hayashi, Takuo ^a   Kumasaka, Toshio ^b   Mitani, Keiko ^a   Yao, Takashi ^a   Suda, Koichi ^a   Seyama, Kuniaki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

ADENOMA; ADULT; AGED; ARTICLE; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; LUNG ALVEOLUS CELL CARCINOMA; LUNG PARENCHYMA; MALE; NODULAR HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBEROUS SCLEROSIS;

ADULT; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LUNG DISEASES; MIDDLE AGED; PNEUMOCYTES; POLYMERASE CHAIN REACTION; TUBEROUS SCLEROSIS;

EID: 77956291444     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.114     Document Type: Article

References (33)

1. Knudson AG. Chasing the cancer demon. Annu Rev Genet 2000;34:1-19.
2. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-808.
3. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-1315.
4. Harris TE, Lawrence Jr JC. TOR signaling. Sci STKE 2003;2003:re15.
5. Jacinto E, Hall MN. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 2003;4:117-126.
6. Karbowniczek M, Henske EP. The role of tuberin in cellular differentiation: are B-Raf and MAPK involved? Ann NY Acad Sci 2005;1059:168-173.
7. Popper HH, Juettner-Smolle FM, Pongratz MG. Micronodular hyperplasia of type II pneumocytes a new lung lesion associated with tuberous sclerosis. Histopathology 1991;18:347-354.
8. Guinee D, Singh R, Azumi N, et al. Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. Mod Pathol 1995;8:902-906.
9. Flieder DB, Travis WD. Clear cell sugar tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. Am J Surg Pathol 1997;21:1242-1247.
10. Lantuejoul S, Ferretti G, Negoescu A, et al. Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis. Histopathology 1997;30:570-575.
11. Muir TE, Leslie KO, Popper H, et al. Micronodular pneumocyte hyperplasia. Am J Surg Pathol 1998; 22:465-472.
12. Yamanaka A, Kitaichi M, Fujimoto T, et al. Multifocal micronodular pneumocyte hyperplasia in a postmenopausal woman with tuberous sclerosis. Virchows Arch 2000;436:389-392.
13. Matsumoto S, Nishioka T, Akiyama T. Renal angiomyolipoma associated with micronodular pneumocyte hyperplasia of the lung with tuberous sclerosis. Int J Urol 2001;8:242-244.
14. Maruyama H, Seyama K, Sobajima J, et al. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene. Mod Pathol 2001;14:609-614.
15. Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001;164:661-668.
16. Fujitaka K, Isobe T, Oguri T, et al. A case of micronodular pneumocyte hyperplasia diagnosed through lung biopsy using thoracoscopy. Respiration 2002;69:277-279.
17. Kobashi Y, Yoshida K, Miyashita N, et al. Multifocal micronodular pneumocyte hyperplasia in a man with tuberous sclerosis. Intern Med 2005;44:462-466.
18. Kobayashi T, Satoh K, Ohkawa M. Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis. Acta Radiol 2005;46:37-40.
19. Kamiya H, Shinoda K, Kobayashi N, et al. Tuberous sclerosis complex complicated by pulmonary multinodular shadows. Intern Med 2006;45:275-278.
20. Saito M, Yuasa T, Satoh S, et al. Developing multiple lung nodules in a renal transplant recipient with tuberous sclerosis who had undergone bilateral nephrectomy due to renal cell carcinomas. Int J Urol 2008;15:257-258.
21. Kobashi Y, Sugiu T, Mouri K, et al. Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis: differentiation from multiple atypical adenomatous hyperplasia. Jpn J Clin Oncol 2008;38:451-454.
22. Cancellieri A, Poletti V, Corrin B. Respiratory failure due to micronodular type II pneumocyte hyperplasia. Histopathology 2002;41:263-265.
23. Takamochi K, Ogura T, Suzuki K, et al. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol 2001;159:1941-1948.
24. Minami Y, Matsuno Y, Iijima T, et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer 2005;48:339-348.
25. Yu J, Astrinidis A, Henske EP. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med 2001;164:1537-1540.
26. Sato T, Seyama K, Fujii H, et al. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 2002;47:20-28.
27. Smolarek TA, Wessner LL, McCormack FX, et al. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 1998;62:810-815.
28. Kumasaka T, Seyama K, Mitani K, et al. Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol 2005;29:1356-1366.
29. Lesma E, Sirchia SM, Ancona S, et al. The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells. Am J Pathol 2009;174:2150-2159.
30. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-1075.
31. Dobashi Y, Suzuki S, Matsubara H, et al. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas. Cancer 2009;115:107-118.
32. Chiang GG, Abraham RT. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem 2005; 280:25485-25490.
33. Bjornsson J, Short MP, Kwiatkowski DJ, et al. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol 1996; 149:1201-1208.